The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research
Wednesday, February 19, 2014
New Phase IIa Trial in the United States and Phase III Trial in...
CardioCell LLC announces two new clinical trials using its allogeneic stem-cell therapy to treat subjects with acute myocardial infarction , a problem facing more than 1.26 million Americans annually.
No comments:
Post a Comment